<Disease><Name>PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)</Name><Synonym>ZELLWEGER SYNDROME</Synonym><OMIM><Number>214100</Number><URL>http://omim.org/entry/214100</URL></OMIM><Orphanet><Number>912</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=912</URL></Orphanet><Protein><Number>Peroxisome biogenesis factor 1</Number><URL>http://www.uniprot.org/uniprot/O43933</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>7q21.2</Gene><ICD>Q87.8</ICD><Summary>rare (1:25000 - 1:50000);autosomal recessive ;mutation in the PEX1 gene;Peroxisome biogenesis disorders; in the Zellweger spectrum (PBD-ZSD) are a heterogeneous group of genetic disorders caused by mutations in PEX genes responsible for normal peroxisome assembly and functions [Braverman NE 2016]</Summary><Symptoms><symtomp><id>3471</id><symptom>brain malformation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2219</id><symptom>buphthalmus</symptom><category>EYES</category></symtomp><symtomp><id>1736</id><symptom>cataract</symptom><category>EYES</category></symtomp><symtomp><id>2257</id><symptom>cholestasis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1997</id><symptom>cirrhosis or fibrosis of liver</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2208</id><symptom>clitoral hypertrophy</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3377</id><symptom>clubfoot</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>1720</id><symptom>congenital heart defect</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2221</id><symptom>cryptorchism</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1782</id><symptom>epicanthus or medial eyelid fold</symptom><category>EYES</category></symtomp><symtomp><id>3943</id><symptom>epiphyseal and periarticular calcific stippling / bony stippling</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2217</id><symptom>glaucoma</symptom><category>EYES</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2220</id><symptom>high arched palate</symptom><category>HEAD</category></symtomp><symtomp><id>1768</id><symptom>high forehead</symptom><category>HEAD | HEAD</category></symtomp><symtomp><id>2619</id><symptom>hydronephrosis</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2214</id><symptom>hyporeflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2320</id><symptom>hypospadia</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1789</id><symptom>large mid-face (broad, prominent)</symptom><category>HEAD</category></symtomp><symtomp><id>2380</id><symptom>liver failure</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2218</id><symptom>low set ears</symptom><category>EARS</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2426</id><symptom>MRI, brain, white matter abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2127</id><symptom>osteoporosis</symptom><category>SKELATAL DEFECT</category></symtomp><symtomp><id>2242</id><symptom>Peroxisomes, liver</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2490</id><symptom>Plasmalogens, biosynthesis</symptom><category>LABORATORY FINDINGS | LABORATORY FINDINGS</category></symtomp><symtomp><id>3875</id><symptom>polycystic kidneys</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1773</id><symptom>ptosis (drooping eyelid)</symptom><category>EYES</category></symtomp><symtomp><id>2688</id><symptom>pulmonary hypoplasia / lung hypoplasia</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>2122</id><symptom>renal cysts</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1731</id><symptom>retinitis pigmentosa</symptom><category>EYES</category></symtomp><symtomp><id>1754</id><symptom>round facies (moon-face, broad)</symptom><category>HEAD</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1697</id><symptom>shortened gestation time</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1700</id><symptom>small for gestational age (SGA), intrauterine growth retardation (IUGR)</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2355</id><symptom>valvular heart disease</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3902</id><symptom>white matter changes, abnormalities</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1593</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>1.60</min><max>14.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>1597</id><name>Azelaic acid</name><specimen>urine</specimen><value>increased</value><min>1.80</min><max>4.80</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1677</id><name>Pimelic acid</name><specimen>urine</specimen><value>increased</value><min>0.70</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1687</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>0.90</min><max>2.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1717</id><name>Pimelic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>74.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1381</id><name>2-Hydroxysebacic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>not detectable</unit><age>childhood 4-6y</age><method /><comment /></metabolite><metabolite><id>1380</id><name>2-Hydroxysebacic acid</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>660</id><name>3-Hydroxysebacic acid</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>6.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>662</id><name>3-Hydroxysebacic acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>663</id><name>3-Hydroxysebacic acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>adolescence</age><method /><comment /></metabolite><metabolite><id>659</id><name>3-Hydroxysebacic acid</name><specimen>urine</specimen><value>increased</value><min>1.50</min><max>24.10</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>661</id><name>3-Hydroxysebacic acid</name><specimen>urine</specimen><value>increased</value><min>0.10</min><max>7.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1315</id><name>8-iso-prostaglandin  F2alpha</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>1.00</max><unit>ng/mg creatinine</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>99</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>7.00</max><unit>mmol/mol creatinine</unit><age>adolescence</age><method /><comment /></metabolite><metabolite><id>555</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>556</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>15.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>558</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>10.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1441</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>74.00</min><max>610.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>2008</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>843</id><name>Alkyl-dihydroxyacetone-phosphate synthase</name><specimen>fibroblasts</specimen><value>increased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1375</id><name>Azelaic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>47.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1374</id><name>Azelaic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>15.00</max><unit>mmol/mol creatinine</unit><age>childhood 4-6y</age><method /><comment /></metabolite><metabolite><id>986</id><name>Azelaic acid</name><specimen>urine</specimen><value>increased</value><min>    </min><max>4.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>501</id><name>Bile acid intermediates</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>438</id><name>C24:0/C22:0</name><specimen>plasma</specimen><value>increased</value><min>0.50</min><max>0.90</max><unit>no unit</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>437</id><name>C26:0</name><specimen>plasma</specimen><value>increased</value><min>0.45</min><max>1.32</max><unit>&#956;mol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>786</id><name>C26:0</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.06</max><unit>&#956;g/ml</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>838</id><name>C26:0</name><specimen>fibroblasts</specimen><value>increased</value><min>0.05</min><max>0.21</max><unit>&#181;g/mg</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>484</id><name>C26:0/C22:0</name><specimen>plasma</specimen><value>increased</value><min>0.01</min><max>0.02</max><unit>no unit</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>839</id><name>C26:0/C22:0</name><specimen>fibroblasts</specimen><value>increased</value><min>0.02</min><max>0.13</max><unit>no unit</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>439</id><name>Hexacosenoic acid C26:1</name><specimen>plasma</specimen><value>increased</value><min>0.02</min><max>0.51</max><unit>&#181;g/ml</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>787</id><name>Hexacosenoic acid C26:1</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>&#956;g/ml</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>495</id><name>Dicarboxylic acids</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>traces</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1121</id><name>Dicarboxylic acids</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>traces</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>837</id><name>Dihydroxyacetone-phosphate acyltransferase (DHAPAT)</name><specimen>fibroblasts</specimen><value>decreased</value><min>3.20</min><max>14.30</max><unit>nmol/2h/mg protein </unit><age>no data</age><method /><comment /></metabolite><metabolite><id>841</id><name>Dihydroxyacetone-phosphate acyltransferase (DHAPAT)</name><specimen>fibroblasts</specimen><value>decreased</value><min>1.60</min><max>3.40</max><unit>nmol/2h/mg protein</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>844</id><name>Dihydroxyacetone-phosphate acyltransferase (DHAPAT)</name><specimen>platelets</specimen><value>decreased</value><min>2.20</min><max>4.90</max><unit>nmol/2h/mg protein</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>447</id><name>Iron</name><specimen>serum</specimen><value>increased</value><min>50.00</min><max>100.00</max><unit>&#181;g/dl</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1084</id><name>Iron</name><specimen>liver</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>840</id><name>Phytanic acid oxidation</name><specimen>fibroblasts</specimen><value>decreased</value><min>5.30</min><max>18.80</max><unit>% oxidized</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>436</id><name>Phytanic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>3.10</max><unit>&#956;g/ml</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>500</id><name>Phytanic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>4.00</max><unit>&#956;g/ml</unit><age>child</age><method /><comment /></metabolite><metabolite><id>881</id><name>Phytanic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>4.00</max><unit>&#956;g/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>433</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>0.50</min><max>35.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method>GCMS</method><comment /></metabolite><metabolite><id>435</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>0.10</min><max>3.50</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>GCMS</method><comment /></metabolite><metabolite><id>2036</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>428</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.80</min><max>5.30</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>429</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.50</min><max>3.80</max><unit>&#181;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>430</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.40</min><max>4.90</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>431</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.70</min><max>2.60</max><unit>&#181;mol/l</unit><age>&gt;5 years</age><method /><comment /></metabolite><metabolite><id>432</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>13.90</min><max>44.70</max><unit>&#181;mol/g creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>434</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>1.60</min><max>13.40</max><unit>&#181;mol/g creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>842</id><name>Plasmalogens, biosynthesis</name><specimen>fibroblasts</specimen><value>increased</value><min>0.40</min><max>0.80</max><unit>3H/14C</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>792</id><name>Pristanic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>&#181;mol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>880</id><name>Pristanic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>1.00</max><unit>nmol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1686</id><name>Sebacic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>2037</id><name>Sebacic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>1378</id><name>Sebacic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>57.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>95</id><name>Sebacic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>94</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>10.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>650</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>14.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>651</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>15.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>653</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>7.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>654</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>6.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2039</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/g creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>378</id><name>Suberic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>1.70</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>379</id><name>Suberic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>10.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>652</id><name>Suberic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>10.10</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>416</id><name>Transaminases (ASAT/ALAT)</name><specimen>serum</specimen><value>normal/inc</value><min>10.00</min><max>30.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>6438</id><title>Metabolic liver diseases presenting with neonatal cholestasis: at the crossroad between old and new paradigms</title><author>Moreira-Silva H,</author><journal>Eur J Pediatr</journal><year>2019</year><book /><volume>178</volume><number>4</number><pages>515-523</pages><co_aut>et al.</co_aut></literature><literature><id>6777</id><title>Hepatic symptoms and histology in 13 patients with a Zellweger spectrum disorder</title><author>Berendse K,</author><journal>J Inherit Metab Dis</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6317</id><title>A clinical case of Zellweger syndrome in a patient with a previous history of ocular medulloepithelioma</title><author>Galvez-Ruiz A,</author><journal>Saudi J Ophthalmol</journal><year>2018</year><book /><volume>32</volume><number>3</number><pages>241-245</pages><co_aut>et al.</co_aut></literature><literature><id>6318</id><title>Brain MRI in a newborn with Zellweger syndrome: ADC quantitation in white matter disease</title><author>Quintas-Neves M,</author><journal>Childs Nerv Syst</journal><year>2018</year><book /><volume>34</volume><number>6</number><pages>1103-1104</pages><co_aut>Carvalho R, Soares-Fernandes JP</co_aut></literature><literature><id>6319</id><title>Zellweger Spectrum Disorder</title><author>Steinberg SJ,</author><journal>Source  GeneReviews&#174; [Internet]</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6323</id><title>Application of machine learning algorithms for the differential diagnosis of peroxisomal disorders</title><author>Subhashini P,</author><journal>J Biochem [Epub ahead of print]</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6320</id><title>Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders</title><author>Klouwer FCC,</author><journal>J Inherit Metab Dis</journal><year>2017</year><book /><volume>40</volume><number>6</number><pages>875-881</pages><co_aut>et al.</co_aut></literature><literature><id>6321</id><title>Zellweger syndrome: Depiction of MRI findings in early infancy at 3.0 Tesla</title><author>Pfeifer CM,</author><journal>Neuroradiol J</journal><year>2017</year><book /><volume>30</volume><number>5</number><pages>442-444</pages><co_aut>Martinot CA</co_aut></literature><literature><id>6322</id><title>Clinical and Laboratory Diagnosis of Peroxisomal Disorders</title><author>Wanders RJ,</author><journal>Methods Mol Biol</journal><year>2017</year><book /><volume>1595</volume><number>0</number><pages>329-342</pages><co_aut>et al.</co_aut></literature><literature><id>4900</id><title>Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines</title><author>Braverman NE,</author><journal>Mol Genet Metab</journal><year>2016</year><book /><volume>117</volume><number>3</number><pages>313-321</pages><co_aut>etv al.</co_aut></literature><literature><id>4902</id><title>Clinical and Biochemical Pitfalls in the Diagnosis of Peroxisomal Disorders</title><author>Klouwer FC,</author><journal>Neuropediatrics</journal><year>2016</year><book /><volume>47</volume><number>4</number><pages>205-220</pages><co_aut>et al.</co_aut></literature><literature><id>6326</id><title>Peroxisome biogenesis and human peroxisome-deficiency disorders</title><author>Fujiki Y</author><journal>Proc Jpn Acad Ser B Phys Biol Sci</journal><year>2016</year><book /><volume>92</volume><number>10</number><pages>463-477</pages><co_aut /></literature><literature><id>4897</id><title>Zellweger spectrum disorders: clinical overview and management approach</title><author>Klouwer FC,</author><journal>Orphanet J Rare Dis</journal><year>2015</year><book /><volume>10</volume><number>0</number><pages>151</pages><co_aut>et al.</co_aut></literature><literature><id>4898</id><title>Revisiting the neuropathogenesis of Zellweger syndrome</title><author>Crane DI</author><journal>Neurochem Int</journal><year>2014</year><book /><volume>69</volume><number>0</number><pages>1-8</pages><co_aut /></literature><literature><id>4899</id><title>Child neurology: Zellweger syndrome</title><author>Lee PR,</author><journal>Neurology. 2013 May 14;80(20):e207-10.</journal><year>2013</year><book /><volume>80</volume><number>20</number><pages>e207-210</pages><co_aut>Raymond GV</co_aut></literature><literature><id>3109</id><title>Genetics and molecular basis of human peroxisome biogenesis disorders</title><author>Waterham HR,</author><journal>Biochim Biophys Acta</journal><year>2012</year><book /><volume>1822</volume><number>9</number><pages>1430-1441</pages><co_aut>Ebberink MS</co_aut></literature><literature><id>3110</id><title>Zellweger Syndrome and Associated Brain Malformations: Report of a Novel Peroxin1(PEX1) Mutation in a Native American Infant</title><author>Mohebbi MR,</author><journal>J Child Neurol</journal><year>2012</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>3111</id><title>A founder mutation in the PEX6 gene is responsible for increased incidence of Zellweger syndrome in a French Canadian population</title><author>Levesque S,</author><journal>BMC Med Genet</journal><year>2012</year><book /><volume>13</volume><number>1</number><pages>72</pages><co_aut>et al.</co_aut></literature><literature><id>6325</id><title>Zellweger-Syndrom</title><author>Kindernetzwerk e.V.</author><journal /><year>2012</year><book /><volume>0</volume><number>0</number><pages /><co_aut /></literature><literature><id>3112</id><title>An infantile case of Zellweger syndrome presented with Kabuki-like phenotype</title><author>Ezgu F;</author><journal>Genet Couns</journal><year>2011</year><book /><volume>22</volume><number>2</number><pages>217-220</pages><co_aut>ET AL:</co_aut></literature><literature><id>1914</id><title>Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders</title><author>Wanders RJ</author><journal>Clin Genet</journal><year>2005</year><book /><volume>67</volume><number>0</number><pages>107-133</pages><co_aut>Waterham HR</co_aut></literature><literature><id>1466</id><title>A new autosomal recessive syndrome with Zellweger-like manifestations</title><author>Ahn JK</author><journal>Am J Med Genet</journal><year>2003</year><book /><volume>119</volume><number>3</number><pages>352-355</pages><co_aut>et al.</co_aut></literature><literature><id>1913</id><title>Biochemical markers predicting survival in peroxisome biogenesis disorders</title><author>Gootjes J</author><journal>Neurology</journal><year>2002</year><book /><volume>59</volume><number>11</number><pages>1746-1749</pages><co_aut>et al.</co_aut></literature><literature><id>1915</id><title>Oral bile Acid treatment in two Japanese patients with Zellweger syndrome</title><author>Maeda K</author><journal>J Pediatr Gastroenterol Nutr</journal><year>2002</year><book /><volume>35</volume><number>0</number><pages>227230</pages><co_aut>et al.</co_aut></literature><literature><id>982</id><title>Plasma very long chain fatty acids in 3000 peroxisome disease patients and 29000 controls</title><author>Moser AB</author><journal>Ann Neurol</journal><year>1999</year><book /><volume>45</volume><number>1</number><pages>100-110</pages><co_aut>et al.</co_aut></literature><literature><id>976</id><title>Specific and rapid quantification of 8-iso-prostaglandin  F2alpha in urine of healthy humans and patients with Zellweger syndrom</title><author>Tsikas D</author><journal>J Chromatogr B Biomed Sci Appl</journal><year>1998</year><book /><volume>716</volume><number>0</number><pages>7-17</pages><co_aut>et al.</co_aut></literature><literature><id>243</id><title>Gest&#246;rter Abbau von 12- und 15-Hydroxyeikosatetraens&#228;ure (HETE) bei Patienten mit peroxisomaler Stoffwechselerkrankung</title><author>Mayatepek E</author><journal>10. Jahrestagung der APS in Fulda</journal><year>1996</year><book>8.-10.2.96</book><volume>0</volume><number>0</number><pages /><co_aut>Lehmann WD</co_aut></literature><literature><id>116</id><title>Disorders of peroxisome biogenesis</title><author>Lazarow PB</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>71</number><pages>2287-2324</pages><co_aut>Moser HW</co_aut></literature><literature><id>227</id><title>Measurement of dihydroxyacetone-phosphate acyltransferase (DHAPAT) in chorionic villous samples, blood cells and cultured cells&lt;</title><author>Wanders RJA</author><journal>J Inher Met Dis Suppl.</journal><year>1995</year><book /><volume>18</volume><number>0</number><pages>90-99</pages><co_aut>et al.</co_aut></literature><literature><id>229</id><title>Peroxisomal disorders</title><author>Heymans HS</author><journal>J Inherit Metab Dis</journal><year>1995</year><book /><volume>0</volume><number>0</number><pages>421-433</pages><co_aut>Wanders RJA, Schutgens RBH</co_aut></literature><literature><id>232</id><title>Clinical approach to inherited peroxisomal disorders</title><author>Poggi-Travert F</author><journal>J Inher Met Dis Suppl</journal><year>1995</year><book /><volume>18</volume><number>0</number><pages>1-18</pages><co_aut>et al.</co_aut></literature><literature><id>546</id><title>MRI findings of Zellweger syndrome</title><author>Nakai A</author><journal>Pediatr Neurol</journal><year>1995</year><book /><volume>13</volume><number>0</number><pages>346-348</pages><co_aut>et al.</co_aut></literature><literature><id>6</id><title>Measurement of Plasma Very Long-Chain Fatty Acids as a Preliminary Screening Procedure for the Diagnosis of Peroxysomal Disorder</title><author>Steinberg SJ</author><journal>J Inher Metab Dis</journal><year>1994</year><book /><volume>17</volume><number>0</number><pages>323-326</pages><co_aut>Fensom AH, Dalton NR, Toseland PA, Kennedy CR, Mowat AP</co_aut></literature><literature><id>13</id><title>A new type of peroxysomal disorder with variable expression in liver and fibroblasts</title><author>Mandel H</author><journal>J Pediatr</journal><year>1994</year><book /><volume>125</volume><number>4</number><pages>549-555</pages><co_aut>Espeel M, Roels F, Sofer N, Luder A, Iancu TC, Aizin A, Berant M, Wanders RJA, Schutgens RBH</co_aut></literature><literature><id>231</id><title>Clinical and biochemical characteristics of peroxisomal disorders: un update</title><author>Wanders RJA</author><journal>Eur J Pediatr Suppl</journal><year>1994</year><book /><volume>153</volume><number>0</number><pages>S44-S48</pages><co_aut>Barth PG, Schutgens RBH, Tager JM</co_aut></literature><literature><id>51</id><title>Peroxysomal Disorders: Concentrations of metabolites in cerebrospinal fluid compared wth plasma</title><author>Ten Brink HJ</author><journal>J Inherit Metab Dis</journal><year>1993</year><book /><volume>16</volume><number>0</number><pages>587-589</pages><co_aut>van den Heuvel CMM, Poll-The BT, Wanders RJA, Jacobs C</co_aut></literature></Literatures></Disease>